COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.
about
Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidusThe Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular DiseasesPhysiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyA novel therapeutic effect of statins on nephrogenic diabetes insipidusNonsteroidal Anti-Inflammatory Drugs and the KidneyAquaporin-6 expression in the cochlear sensory epithelium is downregulated by salicylates.Regulation and dysregulation of aquaporins in water balance disorders.Mice lacking mPGES-1 are resistant to lithium-induced polyuria.Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats.Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissueEffects of biomechanical forces on signaling in the cortical collecting duct (CCD).Increased cyclooxygenase-2 expression and prostaglandin E2 production in pressurized renal medullary interstitial cells.Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output.Aquaporin-2 regulation in health and disease.NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease.New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.Alteration of renal cyclooxygenase expression due to partial unilateral ureteral obstruction in neonatal.ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation.N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.mPGES-1 deletion impairs diuretic response to acute water loading.Lithium induces microcysts and polyuria in adolescent rat kidney independent of cyclooxygenase-2.Chronic kidney disease: targeting prostaglandin E2 receptors.The molecular biology of pelvi-ureteric junction obstruction.Postobstructive diuresis in cats with naturally occurring lower urinary tract obstruction: incidence, severity and association with laboratory parameters on admission.Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.The EP3 receptor regulates water excretion in response to high salt intake.Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.Chronic elevation of IL-1β induces diuresis via a cyclooxygenase 2-mediated mechanism.Albuminuria confers renal resistance to loop diuretics via the stimulation of NLRP3 inflammasome/prostaglandin signaling in thick ascending limb.Rapid and segmental specific dysregulation of AQP2, S256-pAQP2 and renal sodium transporters in rats with LPS-induced endotoxaemia.ROS dependence of cyclooxygenase-2 induction in rats subjected to unilateral ureteral obstruction.Prostaglandin E2 in the Regulation of Water Transport in Renal Collecting Ducts.Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction.COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction.MnTBAP therapy attenuates the downregulation of sodium transporters in obstructive kidney disease.Inhibition of mitochondrial complex-1 restores the downregulation of aquaporins in obstructive nephropathy.Unilateral ureteral obstruction induces DNA repair by APE1.Cisplatin decreases renal cyclooxygenase-2 expression and activity in rats.
P2860
Q24650150-6F08085A-724E-4D9F-90BC-0BA4709A7099Q26768170-87857665-16F7-4A67-9402-999D08BF42B0Q26771378-2B264699-6B5D-4A83-A2DA-D8F809BA0FF4Q27005638-DC22E9D9-7C54-43E6-A4D1-851AAE54F84BQ28386844-81019FDA-001E-4DCA-985B-CEB6734E0E3BQ30483767-EEB95992-D77F-4ED5-A98D-310711F6188FQ31092461-3641DEA2-D4A2-45F3-B8A5-CE477A0AEEB0Q33570060-DC59C00C-08B8-426F-AEC4-2968B2C488E3Q33727799-B6525D90-DBDE-4DAF-94EC-195E5780B447Q33784332-0C9B62AE-B6B8-4152-98F1-88675F7ED637Q34121928-CE0DA436-32DB-47BD-B300-A6A182189DCEQ34150167-64450056-A785-4329-B1BF-373993010D18Q34279269-578A0A03-AA74-4EC1-867C-CD9AB20CD040Q34310224-4448CF3E-0C01-49CE-959E-FB56A77502B2Q35827119-DC2468CB-F134-467B-9EDA-75384D3389E2Q35885150-ABC13920-8496-422F-A6B8-159265CD31E4Q35993741-C709C4A4-D315-4278-AEB1-CB11D1C21FA9Q36728900-ABF2E9BD-4160-46D7-9D8B-543AFE8B0724Q36804822-B612A378-305E-4F14-B0DB-4577C20D4FE4Q36889883-97F9412B-D582-45E1-8FF3-CBA84C833EC6Q37190261-E2B115F4-D018-4B39-961F-632554C536D9Q37668476-C18FF468-A88A-498F-9F12-D974EAC526BBQ38223323-15F15092-DF01-4350-9B47-47B173854A11Q39175631-2AD14714-3D83-4ABB-AF8F-A6B865660592Q39186290-029F7199-6911-4D85-8884-D2161DD01C63Q39227671-9C4AC138-3A55-4D0B-AFA7-F6EF1ED21744Q41630785-16EF4307-C078-416F-9D44-DA52A6EEA2F3Q43182529-6C9789F9-D64C-4445-A43F-5F339ADAD08DQ44016944-EE6A115A-37E5-420C-8616-7442A45051CBQ44162592-09902E23-20E0-424F-BDFA-A5D012A50C5AQ44342501-FF9F63C5-2D62-4D16-834A-7D24BA2D92A6Q46133319-DD2EC465-F871-4073-A35C-1AB0A0DDC46EQ46971883-EA6B893F-49BF-47FD-A0FF-488C95A0E2BCQ47351317-DF65316C-7575-43BD-B94D-4FF84894B88BQ48038002-1F618648-DED6-451A-AE3C-BC41E4230ECFQ48417593-9DCC7ECE-4C96-4827-A9F3-F85290E2648DQ49166588-2367140E-BE1D-420C-853D-121313FB8989Q51642781-56064461-D8E1-45B8-B358-65C2C9E5F79DQ53263415-8BCE55B6-04F4-48ED-A96F-C434601616D3Q54390665-35C63ACB-C801-42B6-A3F8-D382B756E16F
P2860
COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@en
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@nl
type
label
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@en
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@nl
prefLabel
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@en
COX-2 inhibition prevents down ...... ilateral ureteral obstruction.
@nl
P2093
P2860
P50
P1476
COX-2 inhibition prevents down ...... bilateral ureteral obstruction
@en
P2093
Boye L Jensen
Chunling Li
Jørgen Frøkiaer
Mark A Knepper
Søren Nielsen
P2860
P304
P356
10.1152/AJPRENAL.00061.2005
P577
2005-04-19T00:00:00Z